Global Drug Discovery Informatics Market Dynamics 2017: Opportunities, Risks and Driving Factors to 2025

2018-05-02 15:36:25

Global Drug Discovery Informatics Market Expected to Reach XX Million by 2025

According to a new report published by Reports Monitor titled, “Global Drug Discovery Informatics Market, Growth Opportunities, Innovations and Forecast, 2018-2025,” the Drug Discovery Informatics Market was valued at XX million in 2017, and is projected to reach at XX million by 2025, growing at a CAGR of XX% from 2018 to 2025. 

For More Info|Download PDF Brochure :

Drug development as well as discovery informatics is a highly complex process essential for the generation of very costly information and data. Currently the market is emerging area, which creates a sufficient burden on companies for new innovations.

Drug discovery informatics computer applications are used by the pharmaceutical and most of the health care industry. Biotechnological organizations have engaged scientists dedicated to operate drug discovery informatics for a decade or more. The present approaches for building data and proficiency from large amounts of data has been mounting in several cases where the data is largely equivalent or at the very least well-defined. Further application of modern computational and engineering approaches includes visualizing, and analyzing data. Further, it provides meaningful insights, helps to understand complexity and reduce the cost of compliance, and provide intelligent manufacturing process to reduce time-to-market. 

This report provides a detailed analysis of Drug Discovery Informatics, which includes current industry situations such as market size, growth and demands, market outlook, major players with their key strategies. It covers the market canvas and the growth opportunities in the coming years. The report has been made with an in-depth analysis along with important inputs from the various industry experts. The research is carried out with both extensive primary and secondary data sources supported with either bottom up or top down approach.

The global drug discovery informatics market is majorly segmented on the basis function, solution and end-user. Based on end-user drug discovery informatics market is segmented into pharmaceutical and biotechnology as well as contract research organization. Based on function global drug discovery informatics market is bifurcated into target data, sequencing data analysis, molecular docking and library preparation while, based on solution this market is classified into software and services. 

The global Drug Discovery Informatics market is majorly studied across: North America, Europe, Asia Pacific and LAMEA (Latin America, Middle East and Africa). Rising awareness regarding the drug discovery information science within the regions is anticipated to increase the demand for drug discovery information science throughout the forecast period. In North America region technological advancements in the drug discovery informatics is increasing which is the major reason for the market growth in the segment.

The major key players operating in the market are: Charles River laboratories international, Inc., Thermo fisher scientific, PerkinElmer inc., Biogen inc., Boehringer ingelheim GmbH, Insilico medicine, International business machines corporation, Schrödinger, LLC, Albany Molecular Research Inc. (AMRI) and Certara, L.P.

About Garner Insights:

We at Garner provide a comprehensive analysis by providing in-depth reports of the various market verticals. Our Mission is to provide a detailed analysis of the vast markets worldwide backed by rich data. Decision makers can now rely on our well-defined data gathering methods to get the correct and accurate market forecasting along with detailed analysis.

Contact Us:

Kevin Thomas


+1 513 549 5911 (US)

+44 203 318 2846 (UK)

Email: [email protected] 


Related Press Releases